All News #Library
Others
NRx’s Zyesami prevents cytokine storm in Phase IIb/III Covid-19 trial
20 Jul 2021 //
PHARMACEUTICAL-TECHNOLOGY
Israel partners with NRx Pharmaceuticals to commercialize COVID vaccine
13 Jul 2021 //
REUTERS

Market Place
Sourcing Support